Anthera Pharmaceuticals, Inc. (ANTH) Tops Q4 EPS by 4c
Tweet Send to a Friend
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) reported Q4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
